RMBV to Acquire 50% Stake in Egypt’s ATCO Pharma
RMBV signed an agreement to acquire the stake through its RNAF III fund, a source familiar with the transaction told Zawya. Zilla Capital advised ATCO.
Egypt-focused investment firm RMBV has agreed to acquire a 50% stake in local drugmaker ATCO Pharma through its RNAF III fund, according to a source familiar with the transaction who spoke to Zawya. Zilla Capital served as ATCO’s sole financial adviser. The transaction will see RMBV acquire